Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

188 projects found matching your search criteria :

  1. The role of glia cells in the mechanism of therapeutic action of ketogenic diet.

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Zuzanna Setkowicz

    Uniwersytet Jagielloński, Wydział Biologii

  2. Comprehensive analysis of the therapeutic potential of oligonucleotides for the treatment of polyglutamine diseases

    Call: SONATA 9 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej PAN

  3. Structural modifications of bacterial endotoxins (lipopolysaccharides) of significant importance to future antibacterial...

    Call: OPUS 8 , Panel: NZ6

    Principal investigator: dr hab. Jolanta Katarzyna Łukasiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. Identification and structural characterization of the primordial cytotoxic conformers of the amyloidogenic cascade: Idea...

    Call: UNISONO , Panel: NZ1

    Principal investigator: prof. Marek Cieplak

    Instytut Fizyki PAN

  5. DNA repair pathways contributing to resistance to photodynamic therapy and as possible theraupeutic targets

    Call: OPUS 8 , Panel: NZ5

    Principal investigator: dr hab. Elżbieta Speina

    Instytut Biochemii i Biofizyki PAN

  6. The evaluation of influence of genes encoding oxytocin (OXT), dopamine (D) and arginine vasopressin (AVP) precursors pro...

    Call: OPUS 8 , Panel: HS6

    Principal investigator: dr hab. Katarzyna Kucharska

    Instytut Psychiatrii i Neurologii

  7. Evaluation of an influence of interaction between clopidogrel and statins possessing different pharmacokinetic propertie...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  8. Evaluation of therapeutic efficacy of selected azaphenothiazines and studies on the mechanism of the immunosuppressive a...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Michał Zimecki

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  9. Engineering of intelligent inhalable therapeutics with the capacity for guided accumulation and triggered release of act...

    Call: HARMONIA 6 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

  10. Role of the complement system in tumorigenesis and therapeutic approaches.

    Call: SONATA BIS 4 , Panel: NZ6

    Principal investigator: dr hab. Marcin Okrój

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  11. Research on human eosinophils as a potential therapeutic target.

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: Marek Rafał Grosicki

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  12. Analysis of relations on the level of metabolome, miRNome, and transcriptome of human renal cancer: towards identificati...

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  13. Cancer stem cells signaling pathways as a therapeutic terget in ovarian cancer chemotherapy

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: prof. Maciej Zabel

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  14. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

  15. GPR18 orphan receptor. Search for the tools to investigate GPR18 as potential therapeutic target

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  16. Endogenous enkephalinase inhibitors and their novel synthetic analogs as potential new therapeutics for the treatment of...

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  17. Influence of AKT signaling pathway on CD20 expression and antitumor activity of therapeutic monoclonal antibodies.

    Call: OPUS 6 , Panel: NZ5

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  18. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: dr hab. Jadwiga Wardas

    Instytut Farmakologii PAN

  19. Project evaluation of diagnostic, treatment and costs in patients with heart failure among randomly selected outpatient ...

    Call: OPUS 1 , Panel: NZ7

    Principal investigator: prof. Tomasz Kazimierz Grodzicki

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

  20. Mass transport of therapeutic substance from the homogeneous or multi-phase implant which is its reservoir or formation ...

    Call: OPUS 6 , Panel: ST8

    Principal investigator: dr hab. Anna Trusek-Hołownia

    Politechnika Wrocławska, Wydział Chemiczny

  21. BCL11b - Potential Therapeutic Target in T cell Neoplasms

    Call: OPUS 5 , Panel: NZ1

    Principal investigator: dr hab. Grzegorz Przybylski

    Instytut Genetyki Człowieka PAN

  22. Infective endocarditis - the in vitro biomedical analysis of the potential therapeutic properties of selected phytochemi...

    Call: PRELUDIUM 5 , Panel: NZ6

    Principal investigator: Bartłomiej Micota

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  23. Innovative biopreparations with therapeutic activity - chemical and enzymatic methods for production of phospholipids co...

    Call: SONATA 5 , Panel: NZ9

    Principal investigator: dr Anna Gliszczyńska

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Nauk o Żywności

  24. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t...

    Call: PRELUDIUM 5 , Panel: NZ4

    Principal investigator: Joanna Agata Motyl

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  25. Regulation of Expression of Ecto-5'-Nucleotidase - Changes in Pathology and Therapeutic Potential

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Ryszard Tomasz Smoleński

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  26. Evaluation of peroxiredoxins 1 and 2 along with the thioredoxin-thioredoxin reductase system as new therapeutic targets ...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  27. Analysis of immungenecity and therapeutic activity of cell cancer vaccines based on cancer stem cells and induced plurip...

    Call: OPUS 4 , Panel: NZ6

    Principal investigator: prof. Andrzej Mackiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  28. Synthesis and analysis of potential furin inhibitors in the development of the new therapeutic strategies against viral ...

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: Monika Aleksandra Lewandowska-Goch

    Uniwersytet Gdański, Wydział Chemii

  29. Identification of potential therapeutic targets in melanoma stem-like cells

    Call: HARMONIA 3 , Panel: NZ2

    Principal investigator: prof. Małgorzata Ewa Czyż

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski z Oddziałem Stomatologicznym

  30. Identifcation of regulatory effects of bacteriophages with therapeutic potential on mammalian cell functions and immunit...

    Call: SONATA BIS 1 , Panel: NZ6

    Principal investigator: dr hab. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  31. Stimulation of endogenous neurogenesis as a novel therapeutic strategy in neonatal hypoxic-ischemic brain injury.

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Małgorzata Nałęcz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  32. MicroRNA-dependent regulation of adhesion-related molecules in clear cell renal cell carcinoma: the search for markers o...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  33. Interactions between biologically active phytocompounds present in the fodder and selected therapeuticals used in the th...

    Call: SONATA 3 , Panel: NZ9

    Principal investigator: dr hab. Marta Mendel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  34. New reagents and methods in synthesis of modified nucleotides and their application for preparation biochemical tools an...

    Call: SONATA BIS 1 , Panel: ST5

    Principal investigator: dr hab. Jacek Jemielity

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  35. Ventilation, gas exchange and cardiac function in relation to intrapleural pressure changes in patients undergoing thera...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: prof. Rafał Krenke

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  36. Searching for the molecular mechanisms of the therapeutic use of histamine signal and histamine receptors H1R, H2R and H...

    Call: HARMONIA 2 , Panel: NZ6

    Principal investigator: prof. Marek Michał Jutel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

  37. PIM kinases as rational therapeutic targets in lymphoid malignancies.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  38. Targeted Degradation of the MLL Complex in Leukemia: A PROTAC-Based Therapeutic Strategy

    Call: SONATINA 9 , Panel: ST5

    Principal investigator: dr Natalia Anna Skrzypczak

    Fundacja Uniwersytetu im. Adama Mickiewicza

  39. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  40. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

  41. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

  42. Molecular insights into NAD+ metabolism in Huntington's disease: role in pathophysiology and preclinical assessment of t...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny

  43. Porous bioglass-alginate composite granules as the antibiotic delivery system with therapeutic and regenerative potentia...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Adrian Szewczyk

    Gdański Uniwersytet Medyczny

  44. A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Marta Katarzyna Oknińska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  45. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  46. The H3K27M oncohistone-centred molecular mechanisms as therapeutic targets in pediatric malignant diffuse midline glioma...

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Katarzyna Leszczyńska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  47. Exploring DMRTA2 in Glioblastoma: Epigenetic Regulation, Angiogenesis Disruption, and Biomarker Development

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Marta Magdalena Maleszewska-Bobińska

    Uniwersytet Warszawski

  48. Improving the therapeutic potential of cytostatics through the use of abiotic metallacarboranes.

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Michalina Gos

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  49. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

  50. New phosphino derivatives of chinolone antibiotics and their complexes with copper (I) and copper (II) ions. Determinati...

    Call: OPUS 2 , Panel: ST5

    Principal investigator: prof. Małgorzata Janina Jeżowska-Bojczuk

    Uniwersytet Wrocławski, Wydział Chemii